Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03091192
Title Savolitinib vs. Sunitinib in MET-driven PRCC.
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors AstraZeneca
Indications

papillary renal cell carcinoma

Therapies

Sunitinib

Savolitinib

Age Groups: senior | adult
Covered Countries USA | ITA | FRA

Facility Status City State Zip Country Details
Research Site La Jolla California 92093 United States Details
Research Site Atlanta Georgia 30322 United States Details
Research Site Chicago Illinois 60637 United States Details
Research Site Iowa City Iowa 52242 United States Details
Research Site Boston Massachusetts 02215 United States Details
Research Site Kansas City Missouri 64132 United States Details
Research Site New York New York 10021 United States Details
Research Site Nashville Tennessee 37203 United States Details
Research Site Barretos 14784-400 Brazil Details
Research Site Curitiba 81520-060 Brazil Details
Research Site Passo Fundo 99010-080 Brazil Details
Research Site Pelotas 096015-280 Brazil Details
Research Site Porto Alegre 90050-170 Brazil Details
Research Site Porto Alegre 90610-000 Brazil Details
Research Site Porto Alegre 91350-200 Brazil Details
Research Site Rio de Janeiro 22793-080 Brazil Details
Research Site Sao Paulo 01246-000 Brazil Details
Research Site Sao Paulo 01323-903 Brazil Details
Research Site São José do Rio Preto 15090-000 Brazil Details
Research Site Bordeaux 33000 France Details
Research Site Vandoeuvre les Nancy 54519 France Details
Research Site Villejuif 94805 France Details
Research Site Arezzo 52100 Italy Details
Research Site Meldola 47014 Italy Details
Research Site Milano 20133 Italy Details
Research Site Modena 41100 Italy Details
Research Site Orbassano 10043 Italy Details
Research Site Pavia 27100 Italy Details
Research Site Roma 00152 Italy Details
Research Site Daejeon 35015 Korea, Republic of Details
Research Site Goyang-si 10408 Korea, Republic of Details
Research Site Hwasun-gun 58128 Korea, Republic of Details
Research Site Incheon 21565 Korea, Republic of Details
Research Site Seoul 03080 Korea, Republic of Details
Research Site Seoul 03722 Korea, Republic of Details
Research Site Seoul 05538 Korea, Republic of Details
Research Site Seoul 06273 Korea, Republic of Details
Research Site Seoul 135-710 Korea, Republic of Details
Research Site Krasnoyarsk 660133 Russian Federation Details
Research Site Moscow 105077 Russian Federation Details
Research Site Moscow 115478 Russian Federation Details
Research Site Moscow 115522 Russian Federation Details
Research Site Moscow RU-121356 Russian Federation Details
Research Site Murmansk 183047 Russian Federation Details
Research Site Nizhnii Novgorod 603109 Russian Federation Details
Research Site Obninsk 249036 Russian Federation Details
Research Site Omsk 644013 Russian Federation Details
Research Site Saint Petersburg 195271 Russian Federation Details
Research Site St. Petersburg 194017 Russian Federation Details
Research Site Volgograd 400138 Russian Federation Details
Research Site Dnipro 49005 Ukraine Details
Research Site Dnipro 49102 Ukraine Details
Research Site Ivano-Frankivsk 76018 Ukraine Details
Research Site Kharkiv Region 61070 Ukraine Details
Research Site Kyiv 03022 Ukraine Details
Research Site Kyiv 03115 Ukraine Details
Research Site Odesa 65055 Ukraine Details
Research Site Sumy 40022 Ukraine Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field